Skip to main content

Advertisement

SpringerLink
Log in

Association of Level of Proprotein Convertase Subtilisin/Kexin Type 9 with Intima-Media Thickness in Patients with Familial Hypercholesterolemia

  • BIOPHYSICS AND BIOCHEMISTRY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied association of PCSK9 protein with the carotid artery intima-media thickness in patients with familial hypercholesterolemia (N=53; age 49.9±6.9 years) treated with statins. Blood level of PCSK9 protein was measured by ELISA; ultrasonography of the carotid arteries with measurement of the thickness of the intima-media complex of the common carotid arteries in the distal segment for 10 mm from the bifurcation on the far wall of the vessel was performed in on-line mode. The mean values were calculated for both sides, the maximum mean value was included in the analysis. It was shown that PCSK9 levels positively correlate with carotid artery intima-media thickness in patients with familial hypercholesterolemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cheng JM, Oemrawsingh RM, Garcia-Garcia HM, Boersma E, van Geuns RJ, Serruys PW, Kardys I, Akkerhuis KM. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study. Atherosclerosis. 2016;248:117-122.

    Article  CAS  PubMed  Google Scholar 

  2. Gencer B, Montecucco F, Nanchen D, Carbone F, Klingenberg R, Vuilleumier N, Aghlmandi S, Heg D, Räber L, Auer R, Jüni P, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F. Prognostic value of PCSK9 levels in patients with acute coronary syndromes. Eur. Heart J. 2016;37(6):546-553.

    Article  PubMed  Google Scholar 

  3. Kusters DM, Wiegman A, Kastelein JJ, Hutten BA. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ. Res. 2014;114(2):307-310.

    Article  CAS  PubMed  Google Scholar 

  4. Lambert G, Petrides F, Chatelais M, Blom DJ, Choque B, Tabet F, Wong G, Rye KA, Hooper AJ, Burnett JR, Barter PJ, Marais AD. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects. J. Am. Coll. Cardiol. 2014;63(22):2365-2373.

    Article  CAS  PubMed  Google Scholar 

  5. Leander K, Mälarstig A, Van’t Hooft FM, Hyde C, Hellénius ML, Troutt JS, Konrad RJ, Öhrvik J, Hamsten A, de Faire U. Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation. 2016;133(13):1230-1239.

    Article  CAS  PubMed  Google Scholar 

  6. Lim GB. Low prognostic utility of measuring PCSK9 levels in ACS. Nat. Rev. Cardiol. 2016;13(2):62-63.

    Article  PubMed  Google Scholar 

  7. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur. Heart J. 2013;34(45):3478-3490a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Raal F, Panz V, Immelman A, Pilcher G. Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy. J. Am. Heart Assoc. 2013;2(2):e000028.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rogacev KS, Heine GH, Silbernagel G, Kleber ME, Seiler S, Emrich I, Lennartz S, Werner C, Zawada AM, Fliser D, M, März W, Scharnagl H, Laufs U. PCSK9 plasma concentrations are independent of GFR and do not predict cardiovascular events in patients with decreased GFR. PLoS One. 2016;11(1):e0146920.

  10. Shan L, Pang L, Zhang R, Murgolo NJ, Lan H, Hedrick JA. PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide. Biochem. Biophys. Res. Commun. 2008;375(1):69-73.

    Article  CAS  PubMed  Google Scholar 

  11. Tibolla G, Dhyani A, Baragetti A, Catapano AL. Plasma proprotein convertase subtilisin kexin type 9 (PCSK9) and plasma lipids in a free living population: results from the plic study. Atherosclerosis. 2014;235(2):e60. doi: 10.1016/j.atherosclerosis.2014.05.149.

    Article  Google Scholar 

  12. Werner C, Hoffmann MM, Winkler K, Böhm M, Laufs U. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment. Vascul. Pharmacol. 2014;62(2):94-102.

    Article  CAS  PubMed  Google Scholar 

  13. Xie W, Liu J, Wang W, Wang M, Qi Y, Zhao F, Sun J, Liu J, Li Y, Zhao D. Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDLCh: a cohort study. Int. J. Cardiol. 2016;215):293-298.

  14. Zhu YM, Anderson TJ, Sikdar K, Fung M, McQueen MJ, Lonn EM, Verma S. Association of proprotein convertase subtilisin/ kexin type 9 (PCSK9) with cardiovascular risk in primary prevention. Arterioscler. Thromb. Vasc. Biol. 2015;35(10):2254-2259.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Institute of Internal and Preventive Medicine, Novosibirsk, Russia

    K. S. Benimetskaya, Yu. I. Ragino, E. V. Shakhtshneider, K. V. Makarenkova, Yu. V. Shchepina, E. M. Stakhneva & M. I. Voevoda

Authors
  1. K. S. Benimetskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu. I. Ragino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. V. Shakhtshneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. V. Makarenkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu. V. Shchepina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. M. Stakhneva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. I. Voevoda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. S. Benimetskaya.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 2, pp. 160-163, February, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benimetskaya, K.S., Ragino, Y.I., Shakhtshneider, E.V. et al. Association of Level of Proprotein Convertase Subtilisin/Kexin Type 9 with Intima-Media Thickness in Patients with Familial Hypercholesterolemia. Bull Exp Biol Med 163, 199–202 (2017). https://doi.org/10.1007/s10517-017-3765-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3765-3

Key Words

Search

Navigation